Abstract
INTRODUCTION
Dementia prevention research increasingly uses multimodal interventions. Harmonized biomarker practices are essential to enable comparable cross-population analysis with initiatives such as the World-Wide FINGERS (WW-FINGERS) network contributing to this effort.
METHODS
To advance globally representative biomarker research in dementia prevention trials, we conducted a cross-sectional, network-wide survey of WW-FINGERS teams assessing biospecimen collection, processing and storage, biomarker measurements, and readiness for harmonized procedures.
RESULTS
Most studies (30/39) had or were developing biorepositories; four planned collection and five had none. Practices were broadly aligned, but remaining variability highlights priority targets for harmonization. Clinical biomarkers (lipids, glucose, liver/kidney function) were obtained even in lower-resourced settings. Many studies measured Alzheimer’s disease and related dementias (ADRD) biomarkers (blood-based amyloid/tau and neurodegeneration; cerebrospinal fluid where feasible) and increasingly used multi-omics platforms. Evidence-based preanalytical guidance were provided.
CONCLUSION
The WW-FINGERS biorepository provides a world-first platform for harmonized biomarker discovery across diverse populations in dementia prevention, helping to reduce inequities in research participation, accelerating globally representative strategies.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: | November 9, 2026
Neuro-Dementia